← Back to Search

Goal Setting Intervention for Chronic Knee Pain (mGAME Trial)

N/A
Recruiting
Led By Paul Werth, PhD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests how well an intervention helps patients set goals to improve their medical treatment.

Who is the study for?
This trial is for adults over 21 who are new or existing patients scheduled to see an orthopaedic surgeon for knee issues. It's not open to those unable to consent, non-English speakers, or anyone less than a year out from prior spine, hip, or knee surgery.
What is being tested?
The study tests a goal development intervention that helps patients set and track specific and measurable goals for their knee treatment. The effectiveness of this personalized approach will be evaluated.
What are the potential side effects?
Since the interventions involve setting and tracking treatment goals rather than medical procedures or drugs, traditional side effects are not applicable. However, there may be psychological impacts related to goal attainment success.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To evaluate the effectiveness of the goal development intervention using the Goal Attainment Outcome Measure
Secondary study objectives
To assess the intervention's ability to improve shared decision making using the collaboRATE measure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Goal Development and Tracking InterventionActive Control2 Interventions
Group II: Goal Attainment InterventionActive Control1 Intervention
Group III: Goal Development InterventionActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
537 Previous Clinical Trials
2,539,456 Total Patients Enrolled
1 Trials studying Knee Injuries
Medacta USAIndustry Sponsor
16 Previous Clinical Trials
1,820 Total Patients Enrolled
Paul Werth, PhDPrincipal InvestigatorDartmouth-Hitchcock Medical Center

Media Library

Goal Attainment Clinical Trial Eligibility Overview. Trial Name: NCT05652270 — N/A
Knee Injuries Research Study Groups: Goal Development and Tracking Intervention, Goal Attainment Intervention, Goal Development Intervention
Knee Injuries Clinical Trial 2023: Goal Attainment Highlights & Side Effects. Trial Name: NCT05652270 — N/A
Goal Attainment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05652270 — N/A
~13 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top